|
伐度司他市场分析报告
|
Global Anemia Drugs Market (Iron Deficiency, Sickle Cell, CKD, Aplastic Anemia): Analysis By Region, By Country (2016-2021) (By Type - Iron Deficiency Anemia, Chronic Kidney Disease related Anemia, Sickle Cell Anemia, Aplastic Anemia; By Region-North America, Europe, APAC, Latin America, MEA; By Country - USA, Canada, UK, Germany, India, Brazil, South Africa) Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global anemia drugs market on the basis ...
2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... , TXA127, TY027, Ulinastatin, Umnifenovir, V591, vadadustat, VAFIDEMSTAT, Valsartan (Diovan), Vancomycin, Vazegepant ...
COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... , TXA127, TY027, Ulinastatin, Umnifenovir, V591, vadadustat, VAFIDEMSTAT, Valsartan (Diovan), Vancomycin, Vazegepant ...
Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The anemia in chronic kidney disease market has been comprehensively analyzed in IMARC's new report titled "Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Anemia in chronic ...
|
|
|